Safety and efficacy of sunitinib in patients from Latin America: subanalysis of an expanded access trial in metastatic renal cell carcinoma

BACKGROUND: Sunitinib is an approved treatment for metastatic renal cell carcinoma (mRCC). The safety profile and efficacy of sunitinib were confirmed in a global expanded access trial (ClinicalTrials.gov identifier: NCT00130897). This report presents a subanalysis of the final trial data from patie...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Onco Targets Ther
Asıl Yazarlar: Barrios, Carlos H, Herchenhorn, Daniel, Chacón, Matías, Cabrera-Galeana, Paula, Sajben, Peter, Zhang, Ke
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2016
Konular:
Clinical Trial Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5045222/
https://ncbi.nlm.nih.gov/pubmed/27713637
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S109445
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller